Enzyme:CYP2C19: Revision history

22 May 2026

• curprev 16:5316:53, 22 May 2026 MDElliottMD talk contribs 17,499 bytes +112 Add scope="col" to the data-table column headers for screen-reader association (ADA audit M5; designer-claude 2026-05-22) [automatically checked]
• curprev 02:5502:55, 22 May 2026 MDElliottMD talk contribs m 17,387 bytes 0 MDElliottMD moved page Pharmacopedia:Pharmacogenomics sandbox/Enzyme CYP2C19 to Enzyme:CYP2C19: Migrate enzyme entity pages from Pharmacogenomics sandbox to the new Enzyme: namespace [checked by MDElliottMD]

19 May 2026

• curprev 22:3922:39, 19 May 2026 MDElliottMD talk contribs 17,387 bytes +5,291 Consolidate enzyme entity page to canonical Pharmacopedia: sandbox location per Mark 2026-05-19. Full retrofitted version: history-first spine, collapsible-sortable substrate table, comprehensive-tables pointer, all PMIDs NCBI-eutils-verified, zero em-dashes. For CYP2D6/CYP3A4/CYP2C19 this replaces the earlier pre-retrofit draft with the full version; for the other 8 enzymes this is the first save at the canonical location. Resolves a cross-session sandbox-location duplication: the User:MDEll...
• curprev 16:4316:43, 19 May 2026 MDElliottMD talk contribs 12,096 bytes +12,096 Pharmacogenomics entity page: CYP2C19. Three CPIC Level A indications (clopidogrel + PPIs + SSRIs/voriconazole). Five-phenotype classification PM/IM/NM/RM/UM driven by *2 / *3 / *17 alleles; ancestry-frequency variation called out. Clopidogrel prodrug-activation story; PPI dose-by-phenotype; SSRI QT-prolongation in PMs. 9 inline cites across 4 PMID-verified refs: Wilkinson 2005 NEJM (PMID 15917386), Lee/Luzum 2022 CPIC clopidogrel (PMID 35034351), Lima 2021 CPIC PPI (PMID 32770672), Bousman 2...